Acquisition of a UHPLC-HRMS equipment dedicated to high-throughput lipid analysis in order to carry out non-targeting research (or profiling) of lipid biomarkers, i.e. to map and compare all the lipids constituting a population with a pathology (subjects with digestive cancers, cardiovascular diseases, neurodegenerative diseases, infections, diabetes...) in relation to a control population.